阿尔茨海默病(AD)俗称“老年痴呆症”,是一种严重的神经退行性疾病,该病存在巨大未满足的需求,然而,其药物研发却一直伴随着失败。近期,阿尔茨海默病疗法的开发就接连遭遇滑铁卢。11月24日,诺和诺德公布司美格鲁肽(Ozempic和Wegovy的有效成分)口服片剂,在治疗阿尔茨海默病两项大型III期临床试验中未能达到主要临床终点,试验失败。该项临床试验涉招募了约3800名已接受标准治疗的阿尔茨海默...
Source Link阿尔茨海默病(AD)俗称“老年痴呆症”,是一种严重的神经退行性疾病,该病存在巨大未满足的需求,然而,其药物研发却一直伴随着失败。近期,阿尔茨海默病疗法的开发就接连遭遇滑铁卢。11月24日,诺和诺德公布司美格鲁肽(Ozempic和Wegovy的有效成分)口服片剂,在治疗阿尔茨海默病两项大型III期临床试验中未能达到主要临床终点,试验失败。该项临床试验涉招募了约3800名已接受标准治疗的阿尔茨海默...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.